PLoS ONE (Jan 2023)

Community-based serum chloride abnormalities predict mortality risk.

  • Tali Shafat,
  • Victor Novack,
  • Leonid Barski,
  • Yosef S Haviv

DOI
https://doi.org/10.1371/journal.pone.0279837
Journal volume & issue
Vol. 18, no. 2
p. e0279837

Abstract

Read online

IntroductionThis population-based study aimed to investigate the prognostic value of ambulatory serum chloride abnormalities, often ignored by physicians.MethodsThe study population included all non-hospitalized adult patients, insured by "Clalit" Health Services in Israel's southern district, who underwent at least 3 serum chloride tests in community-based clinics during 2005-2016. For each patient, each period with low (≤97 mmol/l), high (≥107 mmol/l) or normal chloride levels were recorded. A Cox proportional hazards model was used to estimate the mortality risk of hypochloremia and hyperchloremia periods.Results664,253 serum chloride tests from 105,655 subjects were analyzed. During a median follow up of 10.8 years, 11,694 patients died. Hypochloremia (≤ 97 mmol/l) was independently associated with elevated all-cause mortality risk after adjusting for age, co-morbidities, hyponatremia and eGFR (HR 2.41, 95%CI 2.16-2.69, pConclusionIn the outpatient setting, hypochloremia is independently associated with an increased mortality risk. This risk is dose-dependent where the lower the chloride level, the higher is the risk.